Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M
Enanta Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: January 20, 2023
Enanta Pharmaceuticals reported fiscal year 2021 executive compensation information on January 20, 2023.
In 2021, six executives at Enanta Pharmaceuticals received on average a compensation package of $2.6M, a 5% increase compared to previous year.
Average pay of disclosed executives at Enanta Pharmaceuticals
Jay R. Luly, Chief Executive Officer, received $5.3M in total, which increased by 2% compared to 2020. 43% of Luly's compensation, or $2.3M, was in option awards. Luly also received $519K in non-equity incentive plan, $693K in salary, $1.8M in stock awards, as well as $19K in other compensation.
For fiscal year 2021, the median employee pay was $230,731 at Enanta Pharmaceuticals. Therefore, the ratio of Jay R. Luly's pay to the median employee pay was 23 to one.
Brendan Luu, Senior Vice President, Business Development, received a compensation package of $2.5M. 70% of the compensation package, or $1.8M, was in option awards.
Tara L. Kieffer, Senior Vice President, New Product Strategy & Development, earned $2M in 2021.
Yat Sun Or, Chief Scientific Officer, received $2M in 2021, which increases by 8% compared to 2020.
Nathaniel S. Gardiner, General Counsel, earned $1.9M in 2021, a 6% increase compared to previous year.
Paul J. Mellett, Chief Financial Officer, received $1.9M in 2021, which increases by 6% compared to 2020.
Enanta Pharmaceuticals' fiscal year ends on September 30.
Related executives
Nathaniel Gardiner
Enanta Pharmaceuticals
General Counsel
Jay Luly
Enanta Pharmaceuticals
Chief Executive Officer
Brendan Luu
Enanta Pharmaceuticals
Senior Vice President, Business Development
Tara Kieffer
Enanta Pharmaceuticals
Senior Vice President, New Product Strategy & Development
Yat Or
Enanta Pharmaceuticals
Chief Scientific Officer
Paul Mellett
Enanta Pharmaceuticals
Chief Financial Officer
You may also like
Source: SEC filing on January 20, 2023.